Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the case-based implementation of
immune checkpoint inhibitors in endometrial cancer through shared decision making.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/mdt-for-ici-in-ec/
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
- Pathologist: Dr Tjalling Bosse, Leiden, Netherlands
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/mdt-for-ici-in-ec/
Wednesday Aug 09, 2023
Wednesday Aug 09, 2023
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer.
The multidisciplinary team:
- Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria
- Medical oncologist: Dr Ilaria Colombo, Bellinzona, Switzerland
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
Monday Jul 31, 2023
Monday Jul 31, 2023
touchIN CONVERSATION for touchHAEMATOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor
- How to best manage side effects associated with JAK inhibitors
- The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchhaematologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
Monday Jul 31, 2023
Monday Jul 31, 2023
touchIN CONVERSATION for touchONCOLOGY
Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis.
They respond to questions submitted by the HCP audience and provide expert insights on:
- The key considerations when selecting a first-line JAK inhibitor
How to best manage side effects associated with JAK inhibitors
The treatment options following failure on a first-line JAK inhibitor
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/in-conversation-jak-inhibition-in-myelofibrosis
Monday Jul 31, 2023
Monday Jul 31, 2023
|
touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. The experts:
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. For further information visit: touchONCOLOGY |
Monday Jul 31, 2023
Monday Jul 31, 2023
touchPANEL DISCUSSION for touchINFECTIOUS DISEASES
Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake.
The experts:
- Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,
- Prof. Eduardo Franco OC, McGill University, Montreal, Canada,
- Prof. Daniel Kelly OBE, European Cancer Organisation, HPV Action Network, Cardiff, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME.
For further information visit: touchINFECTIOUS DISEASES
Wednesday Jul 26, 2023
Wednesday Jul 26, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer.
The experts
- Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK;
- Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA;
- Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/fulfilling_the_potential_of_her2_targeting_in_crc/
Thursday Jul 20, 2023
Thursday Jul 20, 2023
touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2
Module 1
Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options.
The expert
Professor Simona Sacco - University of L’Aquila, Italy
Module 2
Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization.
The patient advocate
Ms Elena Ruiz de la Torre - European Migraine & Headache Alliance, Spain
The clinical expert
Professor Mamoru Shibata - Ichikawa General Hospital, Chiba, Japan
- This touchPODCAST is for HCPs only.
- This activity is funded by an educational grant from Eli Lilly and Company Limited.
- This medical education is provided by touchIME.
For further information visit our website:
https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/
Tuesday Jul 18, 2023
Tuesday Jul 18, 2023
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.
The experts:
Part 1 (00:00)
- Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
- Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Part 2 (20:20)
- Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
- Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
- Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.
For further information visit: https://touchendocrinologyime.org/radiopharmaceuticals-adult-oncology-primer/